Network

Investing in a Healthy Future

The VIC Investor Network features high-impact, high-return life science companies, with experienced done-it-before management teams, co-investment with experienced investors, and more.

previous arrowprevious arrow
next arrownext arrow
INNOVATION

VIC’s Innovation Ecosystem

Turnkey support through all stages of portfolio companies’ development.

Incubate high-potential ideas for future VIC portfolio companies.

Equity funding for proof-of-concept through commercial product roll-out.

Series A/B funding to reach major value-enhancing milestones.

PORTFOLIO

Our Portfolio Companies

Companies built from the ground up based on high impact technologies exclusively licensed from top research institutions around the world. View All Companies 

Now Funding
Vixiar Medical develops non-invasive devices and systems for monitoring cardiopulmonary diseases, particularly those with significant clinical and economic burden.
Funded
Akeso Biomedical is an animal performance and food safety company developing new solutions to improve gut health and treat bacterial infections using a broad-spectrum chemistry.
Funded
ACQUIRED | BlueInGreen (BIG) designs, manufactures and services the most efficient gas dissolution equipment for water and wastewater treatment.
Funded
Calyxo is developing a disruptive solution for kidney stone removal that is faster, easier, and better for patients, clinicians and hospitals.